Eastwood Bio-Medical Canada Inc. reported results for the second quarter and six months ended April 30, 2023. For the second quarter, the company reported revenue of $0.200203 million compared to $0.242976 million a year ago. Revenue was $0.219651 million compared to $0.265376 million in the prior year. Net loss was CA$0.175832 million compared to CA$0.066502 million a year ago. Basic loss per share from continuing operations was $0.01 compared to $0.01 a year ago. Diluted loss per share from continuing operations was $0.01 compared to $0.01 a year ago.
Revenue for the six-month period was $0.478166 million compared to $0.549519 million a year earlier. Revenue was $0.551838 million compared to $0.633624 million in the prior year. The net loss was CA$0.245065 million compared to CA$0.039602 million a year ago. Basic loss per share from continuing operations was $0.01 compared to $0.01 a year ago. Diluted loss per share from continuing operations was $0.01 compared to $0.01 a year ago.
© S&P Capital IQ
Incurable food practitioner. Tv lover. Award-winning social media maven. Internet guru. Travel aficionado.
;Composite=(type=URL,url=https://images.radio-canada.ca/v1/assets/elements/16x9/outdated-content-2013.png),gravity=SouthEast,placement=Over,location=(0,0),scale=1)
